These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32824740)

  • 1. CB2 Receptors and Neuron-Glia Interactions Modulate Neurotoxicity Generated by MAGL Inhibition.
    Rojo-Bustamante E; Íñigo-Marco I; Abellanas MA; Vinueza-Gavilanes R; Baltanás A; Luquin E; Arrasate M; Aymerich MS
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.
    Ignatowska-Jankowska BM; Ghosh S; Crowe MS; Kinsey SG; Niphakis MJ; Abdullah RA; Tao Q; O' Neal ST; Walentiny DM; Wiley JL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2014 Mar; 171(6):1392-407. PubMed ID: 23848221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.
    Pasquarelli N; Engelskirchen M; Hanselmann J; Endres S; Porazik C; Bayer H; Buck E; Karsak M; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2017 Sep; 124():157-169. PubMed ID: 28373073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective Effect of JZL184 in MPP(+)-Treated SH-SY5Y Cells Through CB2 Receptors.
    Aymerich MS; Rojo-Bustamante E; Molina C; Celorrio M; Sánchez-Arias JA; Franco R
    Mol Neurobiol; 2016 May; 53(4):2312-9. PubMed ID: 25976369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP Transgenic Mice Lacking CB2 Receptors.
    Zhang J; Chen C
    Mol Neurobiol; 2018 Jun; 55(6):4802-4810. PubMed ID: 28733897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
    Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
    Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of minocycline and KML29, a potent inhibitor of monoacylglycerol lipase, in an experimental stroke model: a small-animal positron emission tomography study.
    Yamasaki T; Hatori A; Zhang Y; Mori W; Kurihara Y; Ogawa M; Wakizaka H; Rong J; Wang L; Liang S; Zhang MR
    Theranostics; 2021; 11(19):9492-9502. PubMed ID: 34646382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.
    Iuvone T; Esposito G; De Filippis D; Bisogno T; Petrosino S; Scuderi C; Di Marzo V; Steardo L;
    J Mol Med (Berl); 2007 Dec; 85(12):1379-92. PubMed ID: 17639288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS.
    Chang RC; Chen W; Hudson P; Wilson B; Han DS; Hong JS
    J Neurochem; 2001 Feb; 76(4):1042-9. PubMed ID: 11181823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice.
    Crowe MS; Wilson CD; Leishman E; Prather PL; Bradshaw HB; Banks ML; Kinsey SG
    Br J Pharmacol; 2017 Dec; 174(23):4523-4539. PubMed ID: 28963716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
    Wang J; Zhang X; Yang C; Zhao S
    Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.
    Navarrete F; García-Gutiérrez MS; Aracil-Fernández A; Lanciego JL; Manzanares J
    Neurotherapeutics; 2018 Apr; 15(2):459-469. PubMed ID: 29352424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease.
    Pasquarelli N; Porazik C; Bayer H; Buck E; Schildknecht S; Weydt P; Witting A; Ferger B
    Neurochem Int; 2017 Nov; 110():14-24. PubMed ID: 28826718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats.
    Jiang SK; Zhang M; Tian ZL; Wang M; Zhao R; Wang LL; Li SS; Liu M; Li JY; Zhang MZ; Guan DW
    Eur J Pharmacol; 2015 Aug; 761():1-10. PubMed ID: 25912803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver.
    Habib A; Chokr D; Wan J; Hegde P; Mabire M; Siebert M; Ribeiro-Parenti L; Le Gall M; Lettéron P; Pilard N; Mansouri A; Brouillet A; Tardelli M; Weiss E; Le Faouder P; Guillou H; Cravatt BF; Moreau R; Trauner M; Lotersztajn S
    Gut; 2019 Mar; 68(3):522-532. PubMed ID: 30301768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
    Fernández-Ruiz J; Romero J; Velasco G; Tolón RM; Ramos JA; Guzmán M
    Trends Pharmacol Sci; 2007 Jan; 28(1):39-45. PubMed ID: 17141334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.